May 13, 2020
Thermo Fisher Scientific Inc. plans to build a new commercial manufacturing site in Plainville, MA. The $180-million project will more than double the company’s commercial viral vector capacity to support increasing demand for the development and manufacture of gene therapies and vaccines.
Construction of the new 290,000-square-foot facility is expected to be completed in 2022. The project will add more than 200 jobs and complement the company’s new or recently expanded capacity in Lexington and Cambridge, MA and Alachua, FL.
Headquartered in Waltham, MA, Thermo Fisher strategically selected Plainville to capitalize on its expertise at other Massachusetts locations and draw upon the strong talent pool in the Greater Boston area. The new facility will feature digital connectivity and capabilities that enable operational efficiencies, high quality, data visibility and advanced operator training.
For comments, questions or concerns, please contact Paul Bubny